Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England
Catherine Quinot,
Freja Kirsebom,
Nick Andrews,
Julia Stowe,
Mary Ramsay,
Gavin Dabrera,
Meaghan Kall,
Jamie Lopez Bernal,
Alex Allen
Affiliations
Catherine Quinot
UK Health Security Agency, London, United Kingdom; Corresponding author. UK Health Security Agency, London, United Kingdom.
Freja Kirsebom
UK Health Security Agency, London, United Kingdom
Nick Andrews
UK Health Security Agency, London, United Kingdom; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
Julia Stowe
UK Health Security Agency, London, United Kingdom
Mary Ramsay
UK Health Security Agency, London, United Kingdom; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
Gavin Dabrera
UK Health Security Agency, London, United Kingdom
Meaghan Kall
UK Health Security Agency, London, United Kingdom
Jamie Lopez Bernal
UK Health Security Agency, London, United Kingdom; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom; NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, United Kingdom
